×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Germany Asthma Inhaler Device Market

ID: MRFR/HC/54550-HCR
200 Pages
MRFR Team
June 2025

Germany Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices) andBy End User (Hospitals & Clinics, Homecare)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

Germany Asthma Inhaler Device Market Summary

Industry Developments

In recent months, the Germany Asthma Inhaler Device Market has witnessed several significant developments. Notably, the competition among major players such as Pfizer, Teva Pharmaceuticals, Merck, GlaxoSmithKline, and Boehringer Ingelheim remains intense, particularly as innovation progresses towards smart inhaler technology. In June 2023, Merck expanded its product lineup with a new inhaler device aimed at enhancing delivery efficiency for asthma patients. Additionally, AstraZeneca announced a collaborative venture focused on increasing access to inhaled medications for chronic respiratory diseases within Germany, emphasizing patient-centric approaches. The market has experienced notable valuation growth, with the emerging trend of digital health solutions prompting investments from companies like Roche and Hikma Pharmaceuticals, aiming to integrate data analytics into inhalation therapy. Over the past two years, there was a significant surge in the development of combination inhalers, reflected in the launch of several products in early 2022, further emphasizing the need for advanced therapeutic options. Furthermore, there has been ongoing exploration into merger opportunities among these companies, illustrating strategic positioning amid evolving market dynamics in Germany.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 201898.0(USD Million)
MARKET SIZE 2024107.8(USD Million)
MARKET SIZE 2035232.4(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.233% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Million
KEY COMPANIES PROFILEDPfizer, Teva Pharmaceuticals, Merck, GlaxoSmithKline, Roche, Boehringer Ingelheim, Mundipharma, Chiesi Farmaceutici, UCB, Novartis, Eli Lilly, Sanofi, Hikma Pharmaceuticals, Otsuka Pharmaceutical, AstraZeneca
SEGMENTS COVEREDType, Mode of Operation, End User
KEY MARKET OPPORTUNITIESIncreasing prevalence of asthma, Advancements in inhaler technology, Growing demand for smart inhalers, Rising awareness of asthma management, Expanding geriatrics population with asthma
KEY MARKET DYNAMICSrising asthma prevalence, technological advancements, regulatory compliance, increasing healthcare expenditure, growing awareness and education
COUNTRIES COVEREDGermany

Leave a Comment

FAQs

What is the estimated market size of the Germany Asthma Inhaler Device Market in 2024?

The estimated market size of the Germany Asthma Inhaler Device Market in 2024 is valued at 107.8 million USD.

What is the projected value of the market by 2035?

The projected value of the Germany Asthma Inhaler Device Market by 2035 is 232.4 million USD.

What is the compound annual growth rate (CAGR) for the market from 2025 to 2035?

The compound annual growth rate (CAGR) for the Germany Asthma Inhaler Device Market from 2025 to 2035 is expected to be 7.233%.

Which type of inhaler is expected to dominate the market in terms of value by 2035?

By 2035, Metered Dose Inhalers are expected to dominate the Germany Asthma Inhaler Device Market with a valuation of 104.0 million USD.

What is the anticipated market value for Dry Powder Inhalers in 2035?

The anticipated market value for Dry Powder Inhalers in the Germany Asthma Inhaler Device Market by 2035 is 78.0 million USD.

Who are some of the major players in the Germany Asthma Inhaler Device Market?

Major players in the Germany Asthma Inhaler Device Market include Pfizer, Teva Pharmaceuticals, Merck, and GlaxoSmithKline.

What is the expected market value for Soft Mist Inhalers in 2035?

The expected market value for Soft Mist Inhalers in the Germany Asthma Inhaler Device Market by 2035 is 50.4 million USD.

What are the growth drivers for the Germany Asthma Inhaler Device Market?

Key growth drivers for the Germany Asthma Inhaler Device Market include the increasing prevalence of asthma and advancements in inhaler technology.

How is the competitive landscape of the Germany Asthma Inhaler Device Market characterized?

The competitive landscape of the Germany Asthma Inhaler Device Market is characterized by the presence of several large pharmaceutical companies and their innovative product offerings.

What are the emerging trends in the Germany Asthma Inhaler Device Market?

Emerging trends in the Germany Asthma Inhaler Device Market include the development of smart inhalers and combination therapies for asthma management.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions